Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 68788-7992

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68788-7992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion HCl Extended-release Tablets Usp Xl 300mg (Bupropion 300mg 30 Tab Container Label)

Label of Bupropion Hydrochloride Extended-Release Tablets USP (XL) 300 mg by Preferred Pharmaceuticals Inc. The label shows the product name, strength of 300 mg extended-release tablets, and identifies Accord Healthcare, Inc. of Durham, NC as the manufacturer. It includes a barcode, usage instructions in English and Spanish, and a federal caution about drug transfer restrictions.*

FDA Label Image

Wellbutrin Chemical Structure (Bupropion Structure)

Chemical structure diagram of Bupropion Hydrochloride. The structure shows a chlorinated aromatic ring and functional groups typical of Bupropion, accompanied by the hydrochloride salt notation (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.